Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8 - K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 18, 2026 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware      1 - 8351   31 - 0791746 (State or other ‎ jurisdiction of ‎ incorporation) (Commission File Number) (I.R.S. Employer ‎ Identification ‎ Number) 2600 First Financial Center , 255 East 5th Street , Cincinnati , OH 45202 (Address of principal executive offices)             (Zip Code) Registrant's telephone number, including area code: ( 513 ) 762 - 6690   Title of each class   Trading symbol Name of each exchange on which registered Capital stock $1 par value CHE NYSE Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below): [_]      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [_]      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12) [_]      Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b)) [_]      Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to 12(b) of the Act: Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  Emerging growth company [_] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_] ‎ Page 1 of 3 Item 5.07 Submission of Matters to a Vote of Security Holders (a) On May 18, 2026, Chemed Corporation held its annual meeting of stockholders. (b) Stockholders voted on the matters set forth below: Item 1. Election of Directors. The following directors, who constitute the entire Board of Directors, were elected at the meeting by the votes indicated: Nominee For Against Abstentions Broker non-votes Kevin J. McNamara 11,111,578  204,388  6,735  769,580  Ron DeLyons 11,252,597  62,247  7,858  769,580  Patrick P. Grace 9,368,923  1,946,697  7,082  769,580  Christopher J. Heaney 10,891,279  424,319  7,104  769,580  Thomas C. Hutton 11,053,081  262,174  7,447  769,580  Andrea R. Lindell 10,642,996  672,859  6,847  769,580  Elaine McCarthy 11,173,021  141,697  7,984  769,580  John M. Mount Jr. 11,245,765  69,479  7,458  769,580  George J. Walsh III 10,007,160  1,308,559  6,983  769,580  Item 2. Ratification of Independent Accountants. The proposal to ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the company’s independent accountants for the year ending December 31, 2026, was approved with the following votes: Voted For 11,562,294  Against 523,129  Abstain 6,858  Broker non-votes - Item 3. Executive Compensation. The proposal to approve, on a non-binding basis, the Company’s executive compensation program, was not approved with the following votes: Voted For 4,383,683  Against 6,926,656  Abstain 12,363  Broker non-votes 769,580  Page 2 of 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHEMED CORPORATION Dated:    May 19, 2026 By: /s/ Michael D. Witzeman Michael D. Witzeman Executive Vice President and Chief Financial Officer Page 3 of 3